Cargando…

Implantable Cardioverter-defibrillators for Primary Prevention in Pediatric Patients: What’s Next?

Detalles Bibliográficos
Autor principal:	Van Hare, George F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MediaSphere Medical 2018
Materias:	Expert Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252846/ https://www.ncbi.nlm.nih.gov/pubmed/32494504 http://dx.doi.org/10.19102/icrm.2018.090906

Ejemplares similares

Implantable Cardioverter-defibrillator Use in Structural Heart Disease: Narrowing the Playing Field
por: Ellis, Christopher R.
Publicado: (2018)

Same-day Subcutaneous Implantable Cardioverter-defibrillator Placement and Discharge: Another Step Toward Outpatient Electrophysiology
por: Ellis, Christopher R.
Publicado: (2020)

Perioperative Management of Patients with Implantable Cardioverter Defibrillators
por: Donnelly, Patrick, et al.
Publicado: (2007)

Implantable Cardioverter-Defibrillator for Primary Prevention in Asia
por: Younis, Arwa, et al.
Publicado: (2023)

In Search of Alternate Implantation Sites for Pacemakers and Defibrillators: Pacing Along Creativity and Innovation
por: Aryana, Arash
Publicado: (2019)

The use of implantable cardioverter defibrillators in pediatric patients
por: Campagnucci, V, et al.
Publicado: (2013)

Dutch Outcome in Implantable Cardioverter‐Defibrillator Therapy: Implantable Cardioverter‐Defibrillator–Related Complications in a Contemporary Primary Prevention Cohort
por: van Barreveld, Marit, et al.
Publicado: (2021)

Clinical Risk Stratification for Primary Prevention Implantable Cardioverter Defibrillators
por: Lee, Douglas S., et al.
Publicado: (2015)

Comparison and predictors of implantable cardioverter-defibrillator therapy for primary and secondary prevention
por: Evertz, Reinder, et al.
Publicado: (2023)

Optimizing patient selection for primary prevention implantable cardioverter-defibrillator implantation: utilizing multimodal machine learning to assess risk of implantable cardioverter-defibrillator non-benefit
por: Kolk, Maarten Z H, et al.
Publicado: (2023)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Implantable Cardioverter Defibrillator in Primary and Secondary Prevention of SCD—What We Still Don′t Know
por: Ursaru, Andreea Maria, et al.
Publicado: (2022)

Utilization and Outcomes of Primary Prevention Implantable Cardioverter‐Defibrillators in Patients With Hypertrophic Cardiomyopathy
por: Goldstein, Sarah A., et al.
Publicado: (2023)

Considering the Need to Expand the Indications for Wearable Defibrillator Therapy
Publicado: (2019)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Use of Sacubitril/Valsartan Prior to Primary Prevention Implantable Cardioverter Defibrillator Implantation
por: Ozier, Daniel, et al.
Publicado: (2022)

Assessing Candidacy for Primary Preventative Implantable Cardioverter-defibrillators in Pediatric Patients with Ion Channelopathies: Weighing the Risks and Benefits
por: Townsend, Madeline L., et al.
Publicado: (2018)

Implantable cardioverter-defibrillator in patients awaiting heart transplantation: Reinforcing the bridge to transplant
por: Ariyaratnam, Jonathan P., et al.
Publicado: (2021)

Underutilization of Implantable Cardioverter Defibrillator in Primary Prevention of Sudden Cardiac Arrest
por: Lakshmanadoss, Umashankar, et al.
Publicado: (2011)

Perspective on the New American Heart Association/American College of Cardiology Guidelines for the Management of Adults with Congenital Heart Disease
por: Van Hare, George F.
Publicado: (2018)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
por: Begisbayev, Temirkhan, et al.
Publicado: (2022)

Serum-Based Oxylipins Are Associated with Outcomes in Primary Prevention Implantable Cardioverter Defibrillator Patients
por: Zhang, Yiyi, et al.
Publicado: (2016)

Pause-prevention pacing in an extravascular implantable cardioverter-defibrillator
por: Sagi, Venkata, et al.
Publicado: (2023)

Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator
por: Uslu, Abdulkadir, et al.
Publicado: (2018)

Characteristics of Cardiac Memory in Patients with Implanted Cardioverter-defibrillators: The Cardiac Memory with Implantable Cardioverter-defibrillator (CAMI) Study
por: Haq, Kazi T., et al.
Publicado: (2021)

Influence of primary and secondary prevention indications on anxiety about the implantable cardioverter-defibrillator
por: Rahmawati, Anita, et al.
Publicado: (2016)

Use of Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death in Asia
por: Ueda, Nobuhiko, et al.
Publicado: (2023)

One size fits all, or do we have to rethink optimal programming in implantable cardioverter-defibrillators implanted for secondary prevention?
por: Cakulev, Ivan, et al.
Publicado: (2020)

Process mapping strategies to prevent subcutaneous implantable cardioverter‐defibrillator infections
por: Weiss, Raul, et al.
Publicado: (2022)

Impairment of Quality of Life in Patients with Implanted Subcutaneous Cardioverter Defibrillator (S-ICD) Compared to Implanted Transvenous Cardioverter Defibrillator Therapy
por: Thienel, Manuela, et al.
Publicado: (2022)

Quality of Life in Patients with Implantable Cardioverter Defibrillators
por: Francis, Johnson, et al.
Publicado: (2006)

Electrical Storms in Patients with an Implantable Cardioverter Defibrillator
por: Song, Pil Sang, et al.
Publicado: (2011)

Implantable cardioverter–defibrillator in hypertrophic cardiomyopathy
por: Sanchez, Diego Jimenez, et al.
Publicado: (2018)

Remote Monitoring of Implantable Cardioverter Defibrillator
por: Reynolds, Dwight W, et al.
Publicado: (2006)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)

Programming implantable cardioverter/defibrillators and outcomes
por: Horlbeck, Fritz W., et al.
Publicado: (2015)

Higher defibrillation threshold in methamphetamine cardiomyopathy patients with implantable cardioverter-defibrillator
por: Malhotra, Rakesh, et al.
Publicado: (2017)

Psychological Functioning and Disease-Related Quality of Life in Pediatric Patients With an Implantable Cardioverter Defibrillator
por: Koopman, H. M., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_a0gjkgr1tpsil0mquuqqte5dap